Detail akcie Adiuvo Invest online

Business Summary: Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.
Financial Summary: BRIEF: For the nine months ended 30 September 2023, Adiuvo Investments SA revenues decreased 69% to PLN147K. Net loss applicable to common stockholders decreased 54% to PLN4.7M. Revenues reflect Nutraceutical Platform segment decrease of 92% to PLN16K. Lower net loss reflects Other Segments income totaling PLN1.2M vs. loss of PLN2.5M, Nutraceutical Platform segment loss decrease of 32% to PLN2.9M, Medical Equipment segment loss decrease of 48% to PLN1.3M.